170
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The perspectives of patients and physicians on the role of pharmacists in improving medication adherence in type 2 diabetes: a qualitative study

, ORCID Icon &
Pages 1527-1543 | Published online: 09 Sep 2019

References

  • IDF Diabetes Atlas, Sixth Edition. International Diabetes Federation (IDF); 2013 Available from: http://www.idf.org/diabetesatlas. Accessed 62, 2018.
  • Alhowaish AK. Economic costs of diabetes in Saudi Arabia. J Family Community Med. 2013;20(1):1–7. doi:10.4103/2230-8229.10817423723724
  • Alsairafi Z Use of medicines and devices by adults for the management of type 2 diabetes in Kuwait [doctoral thesis]. London: University College London; 2016.
  • Badawi D, Saleh S, Natafgi N, Mourad Y, Behbehani K. Quality of type II diabetes care in primary health care centres in Kuwait: employment of a Diabetes Quality Indicator Set (DQIS). PLoS One. 2015;10(7):1–12. doi:10.1371/journal.pone.0132883
  • Varela N, Oliveira D, Argilagos C, et al. What is the role of the pharmacist? Physicians’ and nurses’ perceptions in community and hospital settings of Santiago de Cuba. Braz J Pharm Sci. 2011;47(4):709–718. doi:10.1590/S1984-82502011000400007
  • Anaya J, Rivera J, Lawson K, Garcia J, Luna J, Ortiz M. Evaluation of pharmacist-managed diabetes mellitus under a collaboration drug therapy agreement. Am J Health Syst Pharm. 2008;65(19):1841–1845. doi:10.2146/ajhp07008718796426
  • Ministry of Health (MOH). 2014 Annual Health Report. Department of Health Information and Medical Records. Ministry of Health Kuwait.
  • Lemay J, Wahidi M, Al-Taweel D, Bayoud T, Moreau P. Clinical pharmacy in Kuwait: services provided, perceptions and barriers. Saudi Pharm J. 2018;26(4):481–486. doi:10.1016/j.jsps.2018.02.01129844718
  • Jeragh-Alhaddad FB, Waheedi M, Barber ND, Brock TP. Barriers to medication taking among Kuwaiti patients with type 2 diabetes: a qualitative study. Patient Prefer Adherence. 2015;23(9):1491–1503. doi:10.2147/PPA.S86719
  • Mechanic D. Public trust and initiatives for new health care partnership. Milbank Q. 1998;76:281–302. doi:10.1111/1468-0009.000899614423
  • Alhyas L, Nielsen JD, Dawoud D, Majeed A. Factors affecting the motivation of healthcare professional providing care to Emiratis with type 2 diabetes. J R Soc Med. 2013;4(14):1–13.
  • Statistical Review, ed 36. State of Kuwait: general statistics Bureau; 2013 Available from: https://www.e.gov.kw/sites/kgoenglish/Forms/StatisticalReview-2013.pdf. Accessed 730, 2018.
  • Al-Taweel D, Awad AI, Johnson BJ. Pharmacists’ contribution to the delivery of pharmaceutical care to patients with type 2 diabetes in Kuwait. Int J Diabetes Dev Ctries. 2014;34(2):108–115. doi:10.1007/s13410-013-0169-4
  • Al Haqan A, Al-Taweel D, Awad A, Wake D. Pharmacists’ attitudes and role in diabetes management in Kuwait. Med Princ Pract. 2017;26:273–279. doi:10.1159/00045608828114146
  • Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J Multdiscip Healthcare. 2016;9:211–217. doi:10.2147/JMDH.S104807
  • Pope C, Mays N. Qualitative Research in Health Care. UK: Wiley-Blackwell; 2007.
  • Corbin J, Strauss A. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Thousand Oaks: SAGE Inc; 2008.
  • O’Reilly M, Parker N. ‘Unsatisfactory Saturation’: a critical exploration of the notion of saturated sample sizes in qualitative research. Qual Res. 2013;13(2):190–197. doi:10.1177/1468794112446106
  • Luborsky M, Rubinstein R. Sampling in qualitative research: rationale, issues, and methods. PMC. 1995;17(1):89–113.
  • Morse J. Handbook of Qualitative Research: Designing Funded Qualitative Research. Thousand Oaks: SAGE Inc; 1994.
  • Creswell JW. Qualitative Inquiry and Research Design: Choosing among Five Traditions. Thousand Oaks: SAGE Inc; 1998.
  • Glaser B, Strauss A. The Discovery of Grounded Theory. Strategies for Qualitative Research. Piscataway, New Jersey: Transaction; 1967.
  • Burnard P, Gill P, Stewart K, Treasure E, Chadwick B. Analysing and presenting qualitative data. Br Dent J. 2008;204:429–432. doi:10.1038/sj.bdj.2008.29218438371
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa
  • Ritchie J, Spencer L. Analyzing Qualitative Data. London, UK: Routledge; 1994.
  • Smith J, Firth J. Qualitative data analysis: the framework approach. Int J Res Meth Nurs Health Care. 2011;18(2):52–62.
  • Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Medic Res Meth. 2013;13:117. doi:10.1186/1471-2288-13-117
  • Smith F. Analysis of data from focus groups: group interaction-the added dimension. Int J Pharm Pract. 1999;7:192–196. doi:10.1111/j.2042-7174.1999.tb00968.x
  • Hadi MA, José Closs S. Ensuring rigour and trustworthiness of qualitative research in clinical pharmacy. Int J Clin Pharm. 2016;38(3):641–646.26666909
  • van Nes F, Abma T, Jonsson H, Deeg D. Language differences in qualitative research: is meaning lost in translation? Eur J Ageing. 2010;7(4):313–316. doi:10.1007/s10433-010-0168-y21212820
  • Hambleton RK, Patsula L. Adapting tests for use in multiple languages and cultures. Soc Indic Res. 1998;45(1):153–171. doi:10.1023/A:1006941729637
  • Ansari J. Drug interaction and pharmacist. J Young Pharm. 2010;2(3):326–331. doi:10.4103/0975-1483.6680721042495
  • American Society of Health-System Pharmacists ASHP. Guidelines on pharmacist-conducted patient education and counselling. Am J Health-Syst Pharm. 1997;54:431–434. doi:10.1093/ajhp/54.4.4319043568
  • Armor B, Britton M, Dennis V, Letassy N. A review of pharmacist contributions to diabetes care in the United States. Int J Pharm Pract. 2010;23(3):250–64. doi:10.1177/0897190009336668
  • Wallgren S, Berry-Caban C, Bowers L. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility. Ann Pharmacother. 2012;46(3):317–328. doi:10.1345/aph.1Q56422395245
  • Svarstad B, Mount J, Tabak E. Expert and consumer evaluation of patient medication leaflets provided in U.S. pharmacies. J Am Pharm Assoc. 2005;45(4):443–451. doi:10.1331/1544345054475586
  • Dhippayom T, Krass I. Supporting self-management of type 2 diabetes: is there a role for the community pharmacist? Patient Prefer Adherence. 2015;9:1085–1092. doi:10.2147/PPA.S8244126257514
  • Awad A, Al-Rasheedi A, Lemay J. Public perceptions, expectations, and views of community pharmacy practice in Kuwait. Med Princ Pract. 2017;26:438–446. doi:10.1159/00048166228934755
  • Catic T, Jusufovic F, Tabakovic V. Patients’ perception of community pharmacist in Bosnia and Herzegovina. Mater Sociomed. 2013;25(3):206–209. doi:10.5455/msm.24167438
  • Basheti I, Qunaibi E, Hamadi S, et al. Patient perspectives of the role of the community pharmacist in the middle east: Jordan, United Arab Emirates and Iraq. Pharmacol Pharm. 2014;5:588–599. doi:10.4236/pp.2014.56069
  • Hindi A, Schafheutle E, Jacobs S. Patient and public perspectives of community pharmacies in the United Kingdom: a systematic review. Health Expect. 2018;21(2):409–428. doi:10.1111/hex.2018.21.issue-229114971
  • Azhar S, Hassali M, Ibrahim M. Doctors’ perception and expectations of the role of the pharmacist in Punjab, Pakistan. Trop J Pharm Res. 2010;9(3):205–222. doi:10.4314/tjpr.v9i3.56279
  • El Hajj M, Al-Saeed H, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38(2):330–343. doi:10.1007/s11096-016-0246-026758716
  • Zaidan M, Singh R, Wazaify M, Tahaineh L. Physicians’ perceptions, expectations, and experience with pharmacists at Hamad Medical Corporation in Qatar. J Multidiscip Healthc. 2011;4:85–90. doi:10.2147/JMDH.S1432621544250
  • Wilbur K, Beniles A, Hammuda A. Physician perceptions of pharmacist roles in a primary care setting in Qatar. Global Health. 2012;8(12):1–4. doi:10.1186/1744-8603-8-1222233652
  • Hamadi S, Mahmoud M, Dizaye K, Basheti I. Perceptions, experiences and expectations of physicians regarding the role of the pharmacist in an Iraqi hospital setting. Trop J Pharm Res. 2015;14(2):293–301. doi:10.4314/tjpr.v14i2.15
  • Rayes I, Abdulkarem A. A qualitative study exploring physicians’ perceptions on the role of community pharmacists in Dubai. Pharm Pract (Granada). 2016;14(3):738–742. doi:10.18549/PharmPract.2016.03.73827785161
  • Hughes C, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53(493):600–606.14601335
  • Latif A, Waring J, Watmough D, et al. Examination of England’s New Medicine Service (NMS) of complex health care interventions in community pharmacy. Res Social Adm Pharm. 2016;12(6):966–989. doi:10.1016/j.sapharm.2015.08.01126806858
  • Matowe L, Abahussain E, Al-Saffar N, Bihzad S, Al-Foraih A, Al-Kandery A. Physicians’ perceptions and expectations of pharmacists’ professional duties in government hospitals in Kuwait. Med Princ Pract. 2006;15:185–189. doi:10.1159/00009217916651833
  • Ibrahim O, Ibrahim R. Perception of physicians to the role of clinical pharmacists in United Arab Emirates (UAE). Pharmacol Pharm. 2014;5(9):895–902. doi:10.4236/pp.2014.59100
  • Kelly D, Young S, Phillips L, Clark D. Patient attitudes regarding the role of the pharmacist and interest in expanded pharmacist services. Can Pharm J (Ott). 2014;147(4):239–247. doi:10.1177/171516351453573125360150
  • Ahmed N, Abdulghani M, Allrebdi S, Baobaid M. Perceptions of physicians about clinical pharmacist’s role in Al Qassinm’s Hospitals in Saudi Arabia. Malaysian J Public Health Medi. 2017;17(3):109–116.
  • Awad A, Abahussain E. Health promotion and education activities of community pharmacists in Kuwait. Pharm World Sci. 2010;32:146–153. doi:10.1007/s11096-009-9360-620039206
  • Alfadl A, Alrasheedy A, Alhassun M. Evaluation of medication counselling practice at community pharmacies in Qassim region, Saudi Arabia. Saudi Pharm J. 2018;26:258–262. doi:10.1016/j.jsps.2017.12.00230166925
  • Younis WS, Campbell S, Slack MK. Pharmacists’ attitudes toward diabetes and their involvement in diabetes education. Ann Pharmacother. 2001;35:841–845. doi:10.1345/aph.1037311485130
  • Simpson S, Haggarty S, Johnson J, Schindel T, Tsuyuki R, Lewansuzuk R. Survey of pharmacist activities and attitudes in diabetes management. Can Pharm J (Ott). 2009;142(3):1–12.
  • Douglas E, Power A, Hudson S. Pharmaceutical care of the patient with diabetes mellitus: pharmacists’ priorities for services and educational needs in Scotland. Int J Pharm Pract. 2010;15(1):47–52. doi:10.1211/ijpp.15.1.0008
  • Saw P, Nissen L, Freeman C, Wong P, Mak V. A qualitative study on pharmacists’ perception in integrating pharmacists into private general practitioner’s clinics in Malaysia. Pharm Pract (Granada). 2017;15(3):1–8. doi:10.18549/PharmPract.2017.03.971
  • Oparah A, Eferakeya A. Attitudes of Nigerian pharmacists towards pharmaceutical care. Pharm World Sci. 2005;27(3):208–214. doi:10.1007/s11096-004-2268-216096889
  • Awad A, Al-Ebrahim S, Abahussain E. Pharmaceutical care services in hospitals of Kuwait. J Pharm Pharm Sci. 2006;9(2):149–157.16959184
  • Katoue M, Awad A, Schwinghammer T, Kombian S. Pharmaceutical care in Kuwait: hospital pharmacists’ perspectives. Int J Clin Pharm. 2014;36(6):1170–1178. doi:10.1007/s11096-014-0013-z25204259
  • Jaam M, Abdbul Hadi M, Kheir N, et al. A qualitative exploration of barriers to medication adherence among patients with uncontrolled diabetes in Qatar: integrating perpectives of patients and health care providers. Patient Prefer Adherence. 2018;12:2205–2216. doi:10.2147/PPA.S17465230410316
  • Dunlop J, Shaw J. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–230. doi:10.1023/A:102152642545812512154
  • van Mil J, de Boer W, Tromp TH. European barriers to the implementation of pharmaceutical care. J Pharm Pract. 2011;9(3):163–168.
  • Al Akshar S, Metwaly Z, Shamssain M. Patients’ perceptions of community pharmacy practice in UAE: an overview. IOSR J Pharm. 2014;4(11):8–14.
  • Mcgrath S, Snyder M, Duenas G. Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis. J Am Pharm Assoc (2003). 2010;50(1):67–71. doi:10.1331/JAPhA.2010.0818620097641
  • Hager K, Uden D, Tomaszewski D. Bridging the location gap: physician perspectives of physician-pharmacist collaboration in patient care (BRIDGE Phase II). J Res Interprof Pract Educ. 2015;5(2):291–298.
  • Kheir N, Zaidan M, Younes H, El Hajj M, Wilber K, Jewesson P. Pharmacy education and practice in 13 middle eastern countries. Am J Pharm Edu. 2008;72(6):133. doi:10.5688/aj7206133
  • Sarabi R, Sadoughi F, Orak R, Bahaadinbeigy K. The effectiveness of mobile phone text messaging in improving medication adherence for patients with chronic diseases: a systematic review. Iran Red Crescent Med J. 2016;18(5):e25183.27437126
  • Schapansky LM, Johnson JA. Pharmacists’ attitudes toward diabetes. Am Pharm Assoc. 2000;40(3):371–377.
  • Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20:71–79. doi:10.1111/j.2042-7174.2011.00165.x22416931
  • Wabe N, Raju N, Angamo M. Knowledge, attitude and practice of patient medication counselling among drug dispensers in North West Ethiopia. J Appl Pharm Sci. 2011;1(7):85–90.
  • Cranor C, Bunting B, Christensen D. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):173–184. doi:10.1331/10865800332148071312688435
  • Hughes J, Wibowo Y, Sunderland B, Hoti K. The role of the pharmacist in the management of type 2 diabetes: current insights and future directions. Integr Pharm Res Pract. 2017;6:15–27. doi:10.2147/IPRP.S10378329354547